Thank you, Brian, and good afternoon, everyone. Total third quarter revenue was $2,000,000 and aligned with the midpoint of our guidance. Total revenue was down 52.5% from Q3 2024 and down 45% compared to Q2 2025. Rounded to the nearest $100,000, new product revenue in Q3 was $1,000,000 and mature product revenue was $1,100,000. New product revenue was down 73.1% from Q3 2024 and down 67.3% compared to Q2 2025. Mature product revenue was up from $700,000 in 2024 and up from $800,000 in 2025. Non-GAAP gross margin in Q3 was a negative 11.9%. This compared with non-GAAP gross margin of 65.3% in Q3 2024 and 31% in Q2 2025. The primary reasons for the lower Q3 gross profit margin are unfavorable absorption of fixed costs due to lower revenue and the fact that $300,000 of R&D cost were allocated to COGS. Non-GAAP operating expenses in Q3 were approximately $2,900,000. This was approximately $300,000 below the midpoint of our outlook due to the COGS allocation I just mentioned. This compares with non-GAAP operating expenses of $3,300,000 in 2024 and $2,500,000 in 2025. Non-GAAP net loss was $3,200,000 or $0.19 per diluted share. This compares to non-GAAP net loss of $900,000 or $0.06 per diluted share in Q3 2024 and a non-GAAP net loss of $1,500,000 or $0.09 per diluted share in 2025. The difference between our GAAP and non-GAAP results is related to non-cash stock-based compensation expenses, impairment charges, and restructuring costs. Stock-based compensation for Q3 was $800,000. Stock-based compensation was $1,200,000 in Q3 2024 and $800,000 in Q2 2025. Impairment charges were $300,000 in Q2 customers accounted for 10% or more of total revenue. At the close of Q3, total cash was $17,300,000 inclusive of utilization of $15,000,000 from our $20,000,000 credit facility. This compares with $19,200,000 inclusive of usage of $15,000,000 from our $20,000,000 credit facility at the close of Q2 2025. Net of approximately $200,000 raised with our ATM in July, cash usage during Q3 was approximately $1,900,000. This was primarily driven by tip-outs and wafer costs associated with our internally financed SRH FPGA test chip. In addition to these one-time costs, there were also expenditures related to revenue contracts and repayments for finance tooling and equipment. Now moving to our guidance and outlook for our fiscal fourth quarter, which will end on December 28, 2025. Based on backlog and customer forecast, we are targeting total revenue of $6,000,000 for Q4. Many of the contracts that support this outlook are already on the books or have been forecasted by customers to be awarded during the coming weeks. However, the customer for a contract valued at nearly $3,000,000 for commercial application has forecasted the award late in the quarter. If this contract is awarded, on or very near the date forecasted, we will be able to recognize a large portion of that revenue in Q4, and with that, realize our $6,000,000 objective. We have a very high level of confidence in winning this contract but note that it could push into Q1 2026. And that would result in Q4 revenue of $3,500,000. Due to this, our guidance range for total Q4 revenue is $3,500,000 to $6,000,000. At $3,500,000, we expect total revenue to be comprised of $2,500,000 in new product revenue and $1,000,000 in mature product revenue. At $6,000,000, we expect $5,000,000 in new product revenue. Based on the anticipated Q4 revenue mix, non-GAAP gross margin for the fourth quarter is expected to be approximately 45% at $3,500,000 of revenue and 68% at $6,000,000 of revenue. At the low end of the range, the primary reason for lower gross profit margin is attributed to less favorable absorption of fixed costs. Taking the range of our Q4 outlook into consideration, our full year 2025 non-GAAP gross profit margin is expected to be 38% plus or minus 5%. Our Q4 non-GAAP operating expenses are expected to be approximately $3,000,000 plus or minus 5%. With this, we are modeling full year 2025 non-GAAP OpEx would be approximately $11,300,000. Please note that given the nature of our industry, we may occasionally need to classify certain expenses to COGS versus OpEx, or capitalize certain costs. These classifications are related to labor and tooling for IP contracts with customers. This may cause variability in our quarterly gross margins and operating results that will usually balance out on the operating line. After interest and other income, at the low end of the revenue range, we forecast a Q4 non-GAAP net loss of approximately $1,900,000 or $0.11 per share. At the high end of our revenue range, we are projecting a non-GAAP net profit of approximately $600,000 or $0.04 per share. The main difference between our GAAP and non-GAAP results is related to non-cash stock-based compensation expenses. In Q4, we expect this compensation will be approximately $800,000. This is the same as Q3 2025 and down slightly from Q4 2024. As a reminder, there will be movement in our stock-based compensation during the year, and it may vary each quarter based on the timing of grants. Even at the low end of our revenue guidance range, we anticipate cash flow in Q4. However, the timing of payments from our US Government contract could negatively impact this outlook. Given the fact that we raised approximately $2,000,000 using our existing ATM in October, we're well prepared for any delayed payments associated with the US government contract. Thank you. With that, let me now turn the call over to Brian for his closing remarks.